HealWELL AI, Inc. is a health care technology company, which focuses on empowering patients and doctors with advanced technologies to increase access, improve quality, and reduce healthcare costs. The company is headquartered in Toronto, Ontario and currently employs 350 full-time employees. The company went IPO on 2007-04-25. The Company, using its own proprietary technology, is developing and commercializing advanced clinical decision support systems that can help healthcare providers detect rare and chronic diseases. The firm's segments include Clinical Research and Patient services, AI and Data sciences and Healthcare Software. The Clinical Research and Patient Services segment includes clinical research contracts and medical consultations provided through the Company's MCI Polyclinic Group Inc. and BioPharma subsidiaries in Ontario. The AI and Data Sciences segment includes integration of advanced AI and data science technologies in healthcare through its Khure Health Inc. and Pentavere and Mutuo subsidiaries. The Healthcare Software segment includes Intrahealth and Versource healthcare software-as-a-service.
Dr. Alexander Dobranowski es el Chief Executive Officer de Healwell AI Inc., se unió a la empresa desde 2020.
¿Qué tal es el rendimiento del precio de la acción HealWELL AI Inc.?
El precio actual de HealWELL AI Inc. es de $0.5833, ha disminuido un 7.02% en el último día de negociación.
¿Cuáles son los temas de negocio principales o las industrias de Healwell AI Inc.?
Healwell AI Inc. pertenece a la industria Health Care y el sector es Health Care
¿Cuál es la capitalización bursátil de Healwell AI Inc.?
La capitalización bursátil actual de Healwell AI Inc. es $171.0M
¿Es Healwell AI Inc. una compra, una venta o una posición de mantener?
Según los analistas de Wall Street, 14 analistas han realizado calificaciones de análisis para Healwell AI Inc., incluyendo 4 fuerte compra, 12 compra, 1 mantener, 0 venta, y 4 fuerte venta